U.S. House pens Medicare vision benefit language, but funding woes threaten derailment
Even as fresh doubts over cost bedevil the Medicare expansion debate on Capitol Hill, a key deadline arrives with Congressional committees including many AOA guardrails in draft language describing new vision benefits.
As of Sept. 15, the date of a self-imposed deadline for select U.S. Senate and House committees to submit their proposed bill language for a historic Medicare vision, hearing and dental coverage expansion, supportive majorities in Congress released their intentions for carving out new vision coverage from the $3.5 trillion budget reconciliation bill. That largely partisan effort does face tough criticism and resistance in Congress, including late-breaking developments that now present a considerable hurdle with funding any benefits expansion at all.
But for its part, the AOA—while not instigating deliberations on a new Medicare vision benefit—is committed to ensuring that should any benefit expansion come to pass, it would work for both doctors of optometry and their patients. Toward that end, preliminary House language that underwent committee markup this week initially proved favorable to many of AOA’s “guardrails” for new vision coverage, including precluding vision discount plans’ oversight, limiting mass retailers’ influence, underscoring optometry’s physician role and preserving the doctor-patient relationship.
The nearly identical language put forth in both the House Ways and Means, and the Energy and Commerce Committees’ drafts defines coverage for routine vision services and a new materials benefit that would preliminarily begin on Oct. 1, 2022. The House committees’ draft language outlines specific requirements, including that:
- Any new benefit be administered directly by Medicare Part B as opposed to being subcontracted to vision discount plans.
- A refraction or contact-lens-fitting service will be provided only under the direct supervision of a state-licensed doctor of optometry or ophthalmologist providing care to a patient in that state.
- The materials benefit will be provided only with an order from said doctor of optometry or ophthalmologist.
- The materials benefit will be placed under the durable medical equipment (DME) program and require competitive bidding except for doctors of optometry and ophthalmologists providing this service to their own patients. The DME program has known challenges such as the surety bond requirements and enrollment fees; however, these same requirements also may serve as deterrents for disreputable retailers.
- The materials benefit will be offered as an allowance so beneficiaries may “purchase up.”
As written, the committees’ draft language defines a two-year frequency for the routine vision service and materials benefit, despite AOA educating lawmakers about concerns that a biannual benefit may undermine public health messages encouraging plans to cover—and patients to seek—annual eye exams. Similarly, the House versions outline materials allowances of $85 for frames and $85 for lenses, or $85 for contact lenses, every two years. Additionally, neither version includes language addressing the low-vision device exclusion despite the AOA’s insistence on closing this gap.
The AOA and optometry’s advocates continue to advocate these latter points prior to a full vote in the House, likely later in September. Separately, the Senate Finance Committee is expected to release its own draft language for a Medicare benefits expansion, yet that version had not been released as of the Sept. 15 deadline.
Such is the case, new developments in the committee markup process this week may forestall expansion of Medicare benefits altogether. Concurrent to the House Ways and Means Committee approval of the draft language expanding Medicare on Wednesday, a trio of key committee members scuppered a provision to allow drug-pricing negotiation in favor of an alternative plan. The drug-pricing measure would have offset some $700 billion over a decade, adding to strong headwinds against Medicare expansion.
AOA’s Special Advisory Group offers advocacy counsel
While the AOA did not initiate Congress’ Medicare expansion efforts, the AOA is determined to shape any legislation by reinforcing the highest standards and value of primary eye health care delivered by doctors of optometry. Throughout this process, the AOA has relied upon the basic guardrails outlined in member feedback as part of its Special Advisory Group on Medicare Expansion. The series of townhall-style webinars—three in as many weeks prior to the Sept. 15 deadline—have proved invaluable to aligning the AOA’s advocacy on behalf of the profession and mobilizing optometry’s advocates to keep members of Congress apprised of what’s at stake with any potential vision benefit expansion.
In fact, AOA President Robert C. Layman, O.D., took a moment in Monday’s special advisory group teleconference to frame the “weedy” policy discussions and emphasize that members of Congress are actively discussing the toll of seniors’ unaddressed eye health and vision care. Noting how 43% of Medicare beneficiaries with trouble seeing lacked an eye exam in the past year, Dr. Layman said Congress’ growing understanding of the costly health outcomes and diminished quality of life from vision loss is critical.
“At the heart of it, we now have a greater recognition in Congress regarding the tremendous value of comprehensive eye care,” Dr. Layman said, acknowledging the years of grassroots involvement from optometry’s advocates that laid groundwork for these conversations.
“But while this increasing recognition by members of Congress regarding the value of the care we provide is positive, that in itself, is simply not enough. If Medicare benefits are expanded and legislation ultimately passes, the care that doctors of optometry provide must be appropriately reimbursed and doctors must retain autonomy to care for patients in the manner that best meets the patient’s unique needs.”
On Monday’s special advisory group call, Dr. Layman also provided updates on the legislative draft process. He underscored positives in the House language; namely, that the benefit remains “squarely” in traditional Medicare, as well as keeping the materials benefit under DME to prevent disreputable retailers from taking advantage of seniors and how language specifically indicates that any new vision benefit may only be provided by a doctor of optometry or ophthalmologist.
Additionally, Dr. Layman addressed concerns that any new vision benefit might “sweep up” certain categories of care already provided to Medicare beneficiaries, i.e., low-vision refractions or specialty contact lenses, and ultimately discounted. He noted Congress’ goal is to create a benefit for routine eye care and that a new benefit would only be covered when using a comprehensive exam code, in addition to the refraction and an appropriate Z code is used.
Should legislation progress to the regulatory phase, Dr. Layman explained, the AOA would advocate with the Centers for Medicare & Medicaid Services (CMS) that exams or refractions outside of the typical Z code would likewise fall outside of the new routine vision care benefit. Those doctors who provide more comprehensive refractions for low vision, or work in specialty contact lenses, would report to Medicare as they’ve done in the past.
Even as developments in the benefit drafting process continue to play out in Congress, Stephen Montaquila, O.D., AOA Federal Relations Committee member, said it’s important that doctors remain involved and continue connecting with their legislators to ensure optometry’s voice is heard on this important conversation.
“One thing that is non-negotiable is that every doctor of optometry is an expert in eye care,” Dr. Montaquila said. “This issue can create an opportunity for relationship building, which is so critical for other legislative efforts for optometry.”
Support the AOA’s Medicare advocacy
To ensure optometry’s physician role is respected and the value of care you provide is understood, the AOA calls on members to bolster the AOA’s advocacy efforts. Here’s how you can act:
- Call your U.S. Senators and House members. Lawmakers are currently writing language that would define any new Medicare vision benefit, and hearing input from not only constituents but also subject matter experts, such as yourself, can help influence this drafting process. Please consider reaching out to your senators or representatives by calling the Capitol Switchboard at 202.224.3121, and share with your legislators these perspectives from our special advisory group.
- Send a letter to your U.S. Senators and House members. Additionally, sending a follow-up letter can help drive home the importance of getting these details right should any policy advance on Capitol Hill. Send a letter by logging in to the AOA’s Action Center or by texting “MEDICARE” to 855.465.5124.
- Provide AOA’s advocacy team with feedback. Doctors, paraoptometrics and optometry students are encouraged to provide the AOA with feedback regarding the expansion of Medicare benefits to include routine vision care. This feedback will help guide the AOA’s advocacy as Congress continues to consider this coverage expansion.
For more information about AOA’s Medicare advocacy or to report on the responses you’ve received from members of Congress, please contact AOA advocacy at email@example.com.
Help advocate for optometry
Visit the AOA’s Action Center to engage priority advocacy issues, such as the Medicare benefits expansion debate, and help build the support in Congress needed to keep optometry’s voice heard.
Medicare’s latest proposed rule builds on efforts to rein back Medicare Advantage plans with the AOA contributing comments that reiterate the need to eliminate plans’ barriers to care and promote transparency.
Ensuring our nation’s veterans have access to the full range of eye care they need, when and where they need it, has long been a mission for optometry’s advocates. Now, a pair of Veterans Health Administration directives affecting optometry could have far-reaching consequences beyond the nation’s largest integrated health care network.
In a recent one-on-one conversation with Federal Trade Commission staff, the AOA again urges the agency to reconsider a proposal requiring patients to sign forms attesting that they have received copies of their eyeglass prescriptions. For small-business optometric practices, the requirement would be burdensome from a paperwork perspective and unnecessary given that consumers are more empowered than ever, the AOA says—again.